NCT00171327View on ClinicalTrials.gov

Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
HypertensionDyslipidemia
Interventions
DRUG

valsartan, fluvastatin

Trial Locations (1)

Unknown

Novartis, Moscow

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY